Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2939 (LINC02939) is a gene that encodes a long intergenic non-coding RNA transcript, which does not overlap annotated coding genes and does not encode a protein[1][3]. LINC02939 is part of the lincRNA molecular class, distinguished by its regulatory functions in chromatin structure, gene expression, and possibly enhancer activity, although the specific cellular functions and disease associations of LINC02939 remain uncharacterized[1][3][5]. LincRNAs, in general, play important roles in fine-tuning expression of neighboring genes, modulating nuclear architecture, scaffolding protein complexes, and participating in RNA stabilization and transcriptional regulation across diverse cellular contexts[3][5]. There is no evidence that LINC02939 is currently considered a therapeutic target, nor are there any known interacting drugs or noted roles in human disease, according to current databases and scientific literature[1][3].\n\nIf more specific function or disease association data emerges, these fields may be updated accordingly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2939 (LINC02939).